Zobrazeno 1 - 10
of 94
pro vyhledávání: '"John F, Boylan"'
Autor:
Eileen A. Friedman, John F. Boylan, Karen Zipf, Ann F. Hoffman, Ann Polonskaia, Kin-chun Luk, Xiaobing Deng, Maria Vilenchik, Jing Hu, Daina Z. Ewton
A major problem in the treatment of cancer arises from quiescent cancer cells that are relatively insensitive to most chemotherapeutic drugs and radiation. Such residual cancer cells can cause tumor regrowth or recurrence when they reenter the cell c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::982e1d19b9983053d3ae3dde4af007fa
https://doi.org/10.1158/1535-7163.c.6535326
https://doi.org/10.1158/1535-7163.c.6535326
Autor:
Eileen A. Friedman, John F. Boylan, Karen Zipf, Ann F. Hoffman, Ann Polonskaia, Kin-chun Luk, Xiaobing Deng, Maria Vilenchik, Jing Hu, Daina Z. Ewton
PDF file - 57K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::328d46e1571d98bc8451fe866053f6ca
https://doi.org/10.1158/1535-7163.22496568
https://doi.org/10.1158/1535-7163.22496568
Autor:
John F. Boylan, Jennifer R. Riggs, Heather K. Raymon, Ning Jiang, Tao Shi, Yuhong Ning, David Mikolon, Tam Tran, Rama Krishna Narla, Leo A. Barnes, Sophie X. Peng, Gordafaried Deyanat-Yazdi, Shuichan Xu, Dan Zhu
Historically, phenotypic-based drug discovery has yielded a high percentage of novel drugs while uncovering new tumor biology. CC-671 was discovered using a phenotypic screen for compounds that preferentially induced apoptosis in triple-negative brea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6bc39d765a5b86cd0bea57f9dd0bcd25
https://doi.org/10.1158/1535-7163.c.6537733
https://doi.org/10.1158/1535-7163.c.6537733
Autor:
Eileen A. Friedman, John F. Boylan, Karen Zipf, Ann F. Hoffman, Ann Polonskaia, Kin-chun Luk, Xiaobing Deng, Maria Vilenchik, Jing Hu, Daina Z. Ewton
PDF file - 286K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19ac18212c658b7ba08ee3ed2fb35a40
https://doi.org/10.1158/1535-7163.22496574.v1
https://doi.org/10.1158/1535-7163.22496574.v1
Autor:
Eileen A. Friedman, John F. Boylan, Karen Zipf, Ann F. Hoffman, Ann Polonskaia, Kin-chun Luk, Xiaobing Deng, Maria Vilenchik, Jing Hu, Daina Z. Ewton
PDF file - 488K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ccfe697436a195197ab6139e1da301d
https://doi.org/10.1158/1535-7163.22496577.v1
https://doi.org/10.1158/1535-7163.22496577.v1
Autor:
Eileen A. Friedman, John F. Boylan, Karen Zipf, Ann F. Hoffman, Ann Polonskaia, Kin-chun Luk, Xiaobing Deng, Maria Vilenchik, Jing Hu, Daina Z. Ewton
PDF file - 78K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49300c2d238b53eef6a5b1e77e7ca1c9
https://doi.org/10.1158/1535-7163.22496571
https://doi.org/10.1158/1535-7163.22496571
Autor:
John F. Boylan, Jennifer R. Riggs, Heather K. Raymon, Ning Jiang, Tao Shi, Yuhong Ning, David Mikolon, Tam Tran, Rama Krishna Narla, Leo A. Barnes, Sophie X. Peng, Gordafaried Deyanat-Yazdi, Shuichan Xu, Dan Zhu
SUPPLEMENTAL METHODS • Correlative analysis of CC-671 sensitivity data with genomic features in the 240 Oncopanel • Correlative analysis of CC-671 sensitivity data with genomic features or tumor subtypes in 49 breast cancer cell lines â
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::345d2d16f0cdc9dbe61ef20d892594b3
https://doi.org/10.1158/1535-7163.22504438.v1
https://doi.org/10.1158/1535-7163.22504438.v1
Autor:
Eileen A. Friedman, John F. Boylan, Karen Zipf, Ann F. Hoffman, Ann Polonskaia, Kin-chun Luk, Xiaobing Deng, Maria Vilenchik, Jing Hu, Daina Z. Ewton
PDF file - 387K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bbb0d061e4df7d708f5b2bc6cb7f280
https://doi.org/10.1158/1535-7163.22496586.v1
https://doi.org/10.1158/1535-7163.22496586.v1
Autor:
Huifeng Niu, David Heimbrook, John F. Boylan, Neal Rosen, Kathryn Packman, Brian Higgins, Christine Rizzo, Yang Wen, Wen-hui Li, Sherif Daouti, Huisheng Wang
Supplementary Figure Legends 1-2 from Identification of the MEK1(F129L) Activating Mutation as a Potential Mechanism of Acquired Resistance to MEK Inhibition in Human Cancers Carrying the B-RafV600E Mutation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f10e8e565bd522991f16622603f03ed
https://doi.org/10.1158/0008-5472.22387878
https://doi.org/10.1158/0008-5472.22387878
Autor:
John F. Boylan, David Heimbrook, Kelli Glenn, Helmut Jacobsen, Roland Jakob-Røtne, Alexander Flohr, Michael Linn, Holly Hilton, Windy Berkofsky-Fessler, James Cai, John Roberts, Daisy Carvajal, Maria Vilenchik, Kathryn Packman, Melissa Smith, Wei He, Leopoldo Luistro
Supplementary Methods and Materials from Preclinical Profile of a Potent γ-Secretase Inhibitor Targeting Notch Signaling with In vivo Efficacy and Pharmacodynamic Properties
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f83d7f21ed746ea9de9d9e721b1ff51
https://doi.org/10.1158/0008-5472.22382880
https://doi.org/10.1158/0008-5472.22382880